The forecast for pancreas malignant neoplasms mortality in Germany from 2024 to 2028 indicates a gradual increase in standardized mortality rates, rising slightly from 20.1 in 2024 to 20.7 by 2028. This upward trend reflects an average annual percentage increase, suggesting a minimally escalating burden. Compared to 2023, the projected data portrays a continuing rise.
Future trends to watch for include advancements in early detection and treatment technologies, as well as potential public health initiatives aimed at reducing risk factors. These could mitigate the predicted rise and potentially improve pancreatic cancer outcomes over the long term.
